Organo Corporation (ORGJF)
Organo Statistics
Share Statistics
Organo has 45.97M shares outstanding. The number of shares has increased by -33.5% in one year.
| Shares Outstanding | 45.97M |
| Shares Change (YoY) | -33.5% |
| Shares Change (QoQ) | -33.5% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 25.48M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 10.86 and the forward PE ratio is null. Organo's PEG ratio is 0.23.
| PE Ratio | 10.86 |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| Forward PS | n/a |
| PB Ratio | 1.84 |
| P/FCF Ratio | 90.44 |
| PEG Ratio | 0.23 |
Enterprise Valuation
Organo has an Enterprise Value (EV) of 206.85B.
| EV / Sales | 1.38 |
| EV / EBITDA | 8.42 |
| EV / EBIT | 55.52 |
| EV / FCF | 99.5 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.11 |
| Quick Ratio | 1.81 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 17.54 |
| Interest Coverage | 93.93 |
Financial Efficiency
Return on Equity is 16.98% and Return on Invested Capital is 11.47%.
| Return on Equity | 16.98% |
| Return on Assets | 9.47% |
| Return on Invested Capital | 11.47% |
| Revenue Per Employee | $59.86M |
| Profits Per Employee | $6.89M |
| Employee Count | 2,512 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 4.88 |
Taxes
| Income Tax | 6.3B |
| Effective Tax Rate | 26.65% |
Stock Price Statistics
The stock price has increased by 96.41% in the last 52 weeks. The beta is 0.78, so Organo's price volatility has been higher than the market average.
| Beta | 0.78 |
| 52-Week Price Change | 96.41% |
| 50-Day Moving Average | 53.03 |
| 200-Day Moving Average | 39.77 |
| Relative Strength Index (RSI) | 30.15 |
| Average Volume (20 Days) | 18 |
Income Statement
In the last 12 months, Organo had revenue of 150.36B and earned 17.31B in profits. Earnings per share was 376.92.
| Revenue | 150.36B |
| Gross Profit | 43.84B |
| Operating Income | 22.54B |
| Net Income | 17.31B |
| EBITDA | 24.55B |
| EBIT | 23.87B |
| Earnings Per Share (EPS) | 376.92 |
Balance Sheet
The company has 17.64B in cash and 36.47B in debt, giving a net cash position of -18.82B.
| Cash & Cash Equivalents | 17.64B |
| Total Debt | 36.47B |
| Net Cash | -18.82B |
| Retained Earnings | 82.91B |
| Total Assets | 177.28B |
| Working Capital | 79.92B |
Cash Flow
In the last 12 months, operating cash flow was 3.73B and capital expenditures -1.65B, giving a free cash flow of 2.08B.
| Operating Cash Flow | 3.73B |
| Capital Expenditures | -1.65B |
| Free Cash Flow | 2.08B |
| FCF Per Share | 45.27 |
Margins
Gross margin is 29.16%, with operating and profit margins of 14.99% and 11.51%.
| Gross Margin | 29.16% |
| Operating Margin | 14.99% |
| Pretax Margin | 15.72% |
| Profit Margin | 11.51% |
| EBITDA Margin | 16.33% |
| EBIT Margin | 14.99% |
| FCF Margin | 1.38% |
Dividends & Yields
ORGJF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 9.21% |
| FCF Yield | 1.11% |
Analyst Forecast
Currently there are no analyst rating for ORGJF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 29, 2022. It was a forward split with a ratio of 4:1.
| Last Split Date | Sep 29, 2022 |
| Split Type | forward |
| Split Ratio | 4:1 |
Scores
| Altman Z-Score | 2.52 |
| Piotroski F-Score | 5 |